DK0389425T3 - Benzothiopyranylaminer - Google Patents

Benzothiopyranylaminer

Info

Publication number
DK0389425T3
DK0389425T3 DK90810193.4T DK90810193T DK0389425T3 DK 0389425 T3 DK0389425 T3 DK 0389425T3 DK 90810193 T DK90810193 T DK 90810193T DK 0389425 T3 DK0389425 T3 DK 0389425T3
Authority
DK
Denmark
Prior art keywords
und
dieser verbindungen
die
werden
psychotischen
Prior art date
Application number
DK90810193.4T
Other languages
English (en)
Inventor
Alan J Hutchison
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of DK0389425T3 publication Critical patent/DK0389425T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Tea And Coffee (AREA)
  • Indole Compounds (AREA)
DK90810193.4T 1989-03-22 1990-03-13 Benzothiopyranylaminer DK0389425T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32694989A 1989-03-22 1989-03-22

Publications (1)

Publication Number Publication Date
DK0389425T3 true DK0389425T3 (da) 1995-05-22

Family

ID=23274473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90810193.4T DK0389425T3 (da) 1989-03-22 1990-03-13 Benzothiopyranylaminer

Country Status (22)

Country Link
US (1) US5071858A (da)
EP (1) EP0389425B1 (da)
JP (1) JPH06102657B2 (da)
KR (1) KR900014357A (da)
AT (1) ATE121740T1 (da)
AU (1) AU632318B2 (da)
CA (1) CA2012569A1 (da)
DD (1) DD292913A5 (da)
DE (1) DE69018864D1 (da)
DK (1) DK0389425T3 (da)
ES (1) ES2071074T3 (da)
FI (1) FI94863C (da)
GR (1) GR3015938T3 (da)
HU (1) HU206205B (da)
IE (1) IE67871B1 (da)
IL (2) IL93814A (da)
MX (1) MX19953A (da)
NO (1) NO174669C (da)
NZ (1) NZ233002A (da)
PT (1) PT93515B (da)
TW (1) TW204347B (da)
ZA (1) ZA902168B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE136461T1 (de) * 1990-08-13 1996-04-15 Searle & Co Verwendung von heterozyklischen aminoalkoholverbindungen zur herstellung eines medikaments für die behandlung von erkrankungen des zns
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5428307A (en) * 1993-10-20 1995-06-27 Silicon Systems, Inc. Closed-loop peak detector topology
JPH0967367A (ja) * 1995-06-23 1997-03-11 Suntory Ltd チオピラン誘導体
FR2739855B1 (fr) * 1995-10-13 1997-11-14 Adir Nouvelles amines heterocycliques tertiaires, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20050148018A1 (en) * 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2077733B1 (da) * 1970-02-10 1973-03-16 Roussel Uclaf
GB1407552A (en) * 1973-04-02 1975-09-24 Science Union & Cie Disubstituted piperazines processes for their preparation and pharmaceutical compositions containing them
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4468404A (en) * 1980-12-12 1984-08-28 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(triazolymethyl)benzo(b)thiophenes
FI79535C (fi) * 1982-05-06 1990-01-10 Erba Farmitalia Foerfarande foer framstaellning av dihydrobensopyrans och dihydrobensotiopyrans substituerade iminoderivat.
GB8515389D0 (en) * 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
ATE65084T1 (de) * 1986-06-26 1991-07-15 Ciba Geigy Ag Hydrierte 1-benzooxacycloalkylpyridincarbons|ureverbindungen.
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
ES2059828T3 (es) * 1988-01-15 1994-11-16 Abbott Lab Un procedimiento para la preparacion de un compuesto.
EP0471515B1 (en) * 1990-08-15 1997-03-05 Eli Lilly And Company Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes

Also Published As

Publication number Publication date
NO901303L (no) 1990-09-24
EP0389425B1 (de) 1995-04-26
MX19953A (es) 1994-01-31
HUT53632A (en) 1990-11-28
ES2071074T3 (es) 1995-06-16
KR900014357A (ko) 1990-10-23
IL93814A (en) 1995-07-31
TW204347B (da) 1993-04-21
NO174669C (no) 1994-06-15
DD292913A5 (de) 1991-08-14
HU901636D0 (en) 1990-11-28
ZA902168B (en) 1990-11-28
JPH06102657B2 (ja) 1994-12-14
CA2012569A1 (en) 1990-09-22
NZ233002A (en) 1992-07-28
FI94863B (fi) 1995-07-31
US5071858A (en) 1991-12-10
AU5208690A (en) 1990-11-08
NO174669B (no) 1994-03-07
DE69018864D1 (de) 1995-06-01
FI94863C (fi) 1995-11-10
HU206205B (en) 1992-09-28
PT93515B (pt) 1996-08-30
IE901036L (en) 1990-09-22
ATE121740T1 (de) 1995-05-15
GR3015938T3 (en) 1995-07-31
IL93814A0 (en) 1990-12-23
FI901371A0 (fi) 1990-03-19
EP0389425A1 (de) 1990-09-26
AU632318B2 (en) 1992-12-24
PT93515A (pt) 1990-11-07
IE67871B1 (en) 1996-05-01
NO901303D0 (no) 1990-03-21
JPH037280A (ja) 1991-01-14

Similar Documents

Publication Publication Date Title
ATE79264T1 (de) Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
DE69008456D1 (de) Filmzusammensetzung zur Behandlung von Oberflächen und Verfahren zu ihrer Herstellung.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE69011985D1 (de) Medizinisches Material, Verfahren zu seiner Herstellung und medizinisches Gerät, in dem dieses Material verwendet wird.
DK0389425T3 (da) Benzothiopyranylaminer
DE59106745D1 (de) Strahlungsempfindliches Gemisch, hiermit hergestelltes strahlungsempfindliches Aufzeichnungsmaterial und Verfahren zur Herstellung von Reliefaufzeichnungen.
DE69006911D1 (de) Verfahren zur Herstellung von 3,4-Dichloranilin.
DE69012808D1 (de) Vorrichtung zur behandlung von lebenden fischen und fischbrut und deren verwendung.
ATE6643T1 (de) Neue 3,4-diaza-bicyclo(4.1.0)hepten-(2)-one-(5), verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel.
DE59106456D1 (de) Verfahren zur Herstellung von linearen 1,3-Diketonen.
ATE113598T1 (de) Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3480706D1 (de) 5-fluoruracilabkoemmlinge sowie medizinische zusammensetzungen die diese enthalten.
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.
DE69000960D1 (de) Zusammensetzung zur behandlung von pigmentierung.
DE69002134D1 (de) Verfahren zur herstellung von 1,1-dichlor-1-fluoroethan und 1-chlor-1-1-difluorethan.
DE59007162D1 (de) Verfahren zur herstellung von 1,4-bis-(4-hydroxybenzoyl)-benzol.
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
PT76582A (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
EP0394644A3 (de) Halogenbenzolderivate
DE69013476D1 (de) Anwendung von Naphthoxazinen.
DE3882023D1 (de) Am aromatischen kern und an der seitenkette fluoratome enthaltende alkoxyaniline und verfahren zur herstellung von am aromatischen kern und an der seitenkette fluoratome enthaltenden alkoxyanilinen.